Lifecore Biomedical, Inc. LFCR Cash Flow Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| -$38.72M— | —— | —— | —— | —— | ||
| $8.03M-1.2% | $8.13M+0.9% | $8.06M+3.6% | $7.78M-2.2% | $7.95M-7.6% | ||
| $10.16M+2.2% | $9.94M+11.9% | $8.88M+25.3% | $7.09M+14.3% | $6.2M+14.4% | ||
| —— | —— | —— | —— | —— | ||
| -$7.69M— | —— | —— | —— | —— | ||
| —— | —— | —— | $1.15M+117% | -$6.68M-7,436% | ||
| -$4.81M-206% | $4.53M+404% | $898K-11.0% | $1.01M-39.0% | $1.65M+124% | ||
| -$378K-203% | $366K+36.1% | $269K+105% | -$5.11M-76.5% | -$2.89M+47.3% | ||
| —— | —— | —— | -$1.71M+6.2% | -$1.83M— | ||
| $2.26M+96.0% | $1.15M— | —— | —— | —— | ||
| —— | $3.16M+480% | $545K-93.2% | $7.97M+3,002% | $257K+102% | ||
| $13.42M-4.4% | $14.03M-6.1% | $14.94M-10.9% | $16.76M-8.9% | $18.4M— | ||
| —— | —— | —— | —— | —— | ||
| -$6.42M+8.8% | -$7.03M+52.9% | -$14.94M+10.9% | -$16.76M+8.9% | -$18.4M+15.8% | ||
| —— | —— | —— | $29.91M— | $0-100% | ||
| $1.27M+9.5% | $1.16M+8.6% | $1.07M+53.6% | $696K+358% | $152K+53.5% | ||
| $6.83M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$18K— | ||
| $2.64M+33.3% | $1.98M+50.0% | $1.32M+100% | $660.5K— | $0— | ||
| -$5.92M-273% | $3.42M— | —— | —— | —— | ||
| $2.91M+104% | $1.42M— | —— | —— | —— | ||
| -$378K-203% | $366K+36.1% | $269K+105% | -$5.11M-76.5% | -$2.89M-12.9% | ||
| —— | —— | —— | -$1.71M+6.2% | -$1.83M— | ||
| —— | —— | —— | $17.14M+11.0% | $15.44M— | ||
| —— | $1.5M-93.5% | $23.1M-45.8% | $42.6M+1.7% | $41.9M0.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $139.94M-4.6% | $146.7M— | ||
| —— | —— | —— | $144.01M-3.7% | $149.59M— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lifecore Biomedical, Inc. generate?
- Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.
- What is Lifecore Biomedical, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.
- Where does Lifecore Biomedical, Inc.'s cash flow data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
